Mary Kay, the direct selling beauty brand, is honouring innovation in skin health research with a new grant programme.
The company has teamed up with non-profit the European Society for Dermatological Research (ESDR) to reward two scientists, who will receive US$20,000 each towards their “groundbreaking” research into skin health and disease.
Mary Kay and the ESDR hope the funds will support new perspectives and strategies to treat patients suffering from skin and venereal diseases.
Dr Michael Cangkrama, a Senior Scientist at the Institute of Molecular Health Sciences at ETH Zürich in Switzerland, has been awarded the grant to support his research into the development and progression of epithelial skin cancers, which are the most common types of cancer in humans.
Also recognised is the UK’s Dr Clarisse Ganier, a Research Associate at the Center of Gene Therapy and Regenerative Medicine in King’s College London, for her work on the Human Cell Atlas initiative, a collaborative project aiming to map all cell types within the human body.
Read more:
- KraveBeauty to support influencers who tackle overconsumption in the beauty industry
- Glossier extends black-owned beauty business grant to the UK
- L’Oréal puts $100k towards dermatology research for skins of colour
“Mary Kay is dedicated to advancing skin and nutritional health research globally, and we know this cannot be done alone,” said Dr Lucy Gildea, Chief Innovation Officer, Product and Science at Mary Kay.
“Collaboration across industries, academic institutions and clinicians is critical, which is why we are proud to partner with ESDR to furnish the first-ever Mary Kay-ESDR Skin Health/Skin Disease Research Grants.
“These grants bring this larger community together for new inspiration for the future, and Mary Kay is proud to be a part of this opportunity.
“We are excited to see how these recipients bring greater advancements to different aspects of skin health research.”
